Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging

References

• Glenner G G, Wang C W. Alzhemer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Blochem Biophys Res Comun 1984; 120: 885–890
   PubMed Web of Science ®Google Scholar
• Masters C L, Simms G, Weinman N, Multhaup A., Mc G., Donald B L, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245–4249
   PubMed Web of Science ®Google Scholar
• Mann D MA, Esiri M M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989; 89: 169–179
   PubMed Web of Science ®Google Scholar
• Roberts G W, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatr 1990; 53: 373–378
   PubMed Web of Science ®Google Scholar
• van Duinen S G, Castano E. M., Prelli F., Bots G TAB, Luyndijk W, Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Nati Acad Sic USA 1987; 484: 5991–5994
   Google Scholar
• Hart M N, Merz P, Bennett-Gray J., Menezes A H, Goeken J A, Schelper R L, Wisniewski H M. Beta-amyloid protein of Alzheimer's disease is found in cerebral and spinal cord vascular malformations. Am J Pathol 1988; 132: 167–172
   PubMed Web of Science ®Google Scholar
• Kang J, Lemaire H-G, Unterbeck A., Salbaum J M, Masters C L, Grzeschik K-H, Beyreuther Multhaup G., Muller K., Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733–736
   PubMed Web of Science ®Google Scholar
• Joachim C L, Duffy L K, Morris J H, Selkoe D J. Protein chemical and immunohistochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res 1988; 474: 100–111
   PubMed Web of Science ®Google Scholar
• Prelli F, Castano E, Glenner G G, Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 1988; 51: 648–651
   PubMed Web of Science ®Google Scholar
• Mori H, Takio K, Ogawara M, Selkoe D J. Mass spectrometry of purified amyloid protein in Alzheimer's disease. J Biol Chem 1992; 24: 17082–17086
   Google Scholar
• Miller D L, Papayannopoulos I A, Styles J, Bobin S A, Lin Y Y, Biemann L K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993; 301: 41–52
   PubMed Web of Science ®Google Scholar
• Roher A E, Lowenson J D, Clarke S, Wolkow C, Wang R, Cotter R J, Reardon I M, Zurcher-Neely H A, Heinrikson R L, Ball M J, Greenberg B D. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. JBiol Chem 1993; 268: 3072–3083
   PubMed Web of Science ®Google Scholar
• Roher A E, Lowenson J D, Clarke S, Woods A S, Cofter R J, Growing E, Ball M J. β-amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc Nati Acad Sci USA 1993; 90: 10836–10840
   PubMed Web of Science ®Google Scholar
• Barrow C J, Yasuda A, Kenny P TM, Zagorski M G. Solution conformation and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease: analysis of circular dichroism spectra. J Mol Biol 1992; 225: 1075–1093
   PubMed Web of Science ®Google Scholar
• Jarrett J T, Lansbury P T. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993; 73: 1055–1058
   PubMed Web of Science ®Google Scholar
• Jarrett J T, Berger E P, Lansbury P T. The carboxyl terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimers disease. Biochemistry 1993; 32: 4693–4697
   PubMed Web of Science ®Google Scholar
• Mullan M, Crawford F, Axelman K, Houldin H, Lilius L, Winblad B, Lannfelt L. A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-ter-minus of β-amyloid. Nature Genet 1992; 1: 345–347
   PubMed Web of Science ®Google Scholar
• Citron M, Oltersdorf T, Haass C, McConlogue L, Hung A Y, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe D J. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992; 360: 672–674
   PubMed Web of Science ®Google Scholar
• Cai X D, Golde T E, Younkin S G. Release of excess amyloid beta protein from a mutant amyloid β protein precursor. Science 1993; 259: 514–516
   PubMed Web of Science ®Google Scholar
• Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rosser M, Owen M, Hardy J. Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–706
   PubMed Web of Science ®Google Scholar
• Murrell J, Farlow M, Ghetti B, Benson M D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991; 254: 97–99
   PubMed Web of Science ®Google Scholar
• Suzuki N, Cheung T T, Cai X-D, Odaka A, Otvos L, Eckman C, Golde T E, Younkin S G. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994; 264: 1366–1340
   Google Scholar
• Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is AB42(43). Neuron 1994; 13: 45–53
   PubMed Web of Science ®Google Scholar
• Murphy G M, Forno L S, Higgins L, Scardina J M, Eng L F, Cordell B. Development of monoclonal antibody specific for the COOH-terminus of β-amyloid 1–42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 1994; 144: 1082–1088
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Ihara Y. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by β protein immunostaining. Acta Neuropathol 1988; 76: 541–549
   PubMedGoogle Scholar
• Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y., Kawarabayashi T, Sun X, Hirai S. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 1994; 88: 413–419
   PubMedGoogle Scholar
• Takashima A, Noguchi K, Sato K, Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc Nati Acad Sci USA 1993; 90: 7789–7793
   PubMed Web of Science ®Google Scholar
• Schagger H, von Gaw G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range of 1 to 100kDa. Anal Biochem 1987; 166: 368–379
   PubMed Web of Science ®Google Scholar
• Khachaturian Z S. Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42: 1097–1105
   PubMed Web of Science ®Google Scholar
• Sugihara S, Ogawa A, Nakazato Y, Yamaguchi H. Cerebral β amyloid deposition in the patients with malignant neoplasms: its incidence with aging and effect of radiation therapy on vascular amyloid. Acta Neuropathol 1994, in submission
   Google Scholar
• Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by β proteir immunostain. Acta Neuropathol 1989; 77: 314–319
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Yamazaki T, Lemere C A, Frosch M P, Selkoe D J. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: an immunoelectron microscopic study. Am J Pathol 1992; 141: 249–259
   PubMed Web of Science ®Google Scholar
• Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses A D, Tjernberg L O, Silberring J, Gandy S E, Winblad B, Greengard P, Nordsted C, Terenius L. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 1994; 91: 8378–8382
   PubMed Web of Science ®Google Scholar
• Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C., Ihara Y. High tissue content of soluble βl-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994; 145: 452–460
   PubMed Web of Science ®Google Scholar
• Glundke-Iqbal I, Iqbal K, George L, Tung Y-C, Kim K S, Wisniewski H M. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 2853–2857
   Google Scholar
• Stern R A, Otvos L, Trajanowski J Q, Lee V. Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease b-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol 1989; 134: 937–978
   Google Scholar
• Haass C, Schlossmacher M, Hung A Y, Vigo-Pelfrey C., Mellon A, Ostaszewski B C, Lieberburg I, Koo E H, Schenk D, Teplow D B, Selkoe D J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 1992; 359: 322–325
   PubMed Web of Science ®Google Scholar
• Shoji M, Golde T E, Ghiso J, Cheung T T, Estus S, Shaffer L M, Cai X D, McKay D M, Tintner R, Frangione B, Younkin S G. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992; 258: 126–129
   PubMed Web of Science ®Google Scholar
• Busciglio J, Gabuzda D H, Matsudaira P, Yankner B A. Generation of β-amyloid in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 1993; 90: 2092–2096
   PubMed Web of Science ®Google Scholar
• Allsop D, Haga S, Bruton C, Ishii T, Roberts G W. Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid β-protein of Alzheimer's disease. Am J Pathol 1990; 136: 255–260
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Nakazato Y, Shoji M, Okamoto K, Ihara Y, Morimatsu M, Hirai S. Secondary deposition of β amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia. Am J Pathol 1991; 138: 699–705
   PubMed Web of Science ®Google Scholar
• Tabaton M, Cammarata S, Manefto V, Autilio-Gambetti L, Perry G, Gambetti P. Ultrastructural localization of β-amyloid, T, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci USA 1991; 88: 2098–2102
   Google Scholar
• Spillantini M G, Goedert M, Jakes R, Klug A. Topographical relationship between β amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease. Proc Natl Acad Sci USA 1990; 87: 3952–3956
   Google Scholar
• Perry G, Cras P, Siedlak S L, Tabaton M, Kawai M. P Protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1992; 140: 283–290
   Google Scholar
• Yamaguchi H, Ishiguro K, Shoji M, Yamazaki T, Ihara Y, Hirai S. Amyloid β protein precursor is bound to neurofibrillary tangles in Alzheimer-type dementia. Brain Res 1990; 537: 318–328
   Google Scholar
• Perry G, Richey P L, Siedlak S L, Smith M A, Mulvihill P, DeWitt D A, Barnett J, Greenberg B D, Kalaria R N. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1993; 143: 1586–1593
   Google Scholar